Hyeon Hwa Kim
Overview
Explore the profile of Hyeon Hwa Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
8
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim H, Lee H, Hennighausen L, Furth P, Sung H, Huh J
Vaccine X
. 2024 Oct;
20:100565.
PMID: 39399820
The widespread administration of an additional dose of the SARS-CoV-2 vaccine has been promoted across adult populations, demonstrating a robust immune response against COVID-19. Longitudinal studies provide crucial data on...
2.
Kim M, Nathan S, Kim H, Kim H
Ther Adv Respir Dis
. 2024 Aug;
18:17534666241275329.
PMID: 39175212
Background: A six-minute walk test (6MWT) is a reproducible, easily performed test, and is widely used to determine functional exercise capacity in patients with idiopathic pulmonary fibrosis (IPF). However, there...
3.
Han S, Kim H, Hyun D, Ji W, Choi C, Lee J, et al.
BMC Pulm Med
. 2024 Mar;
24(1):136.
PMID: 38491506
Background: Lung cancer (LC) is an important comorbidity of interstitial lung disease (ILD) and has a poor prognosis. The clinical characteristics and outcome of each ILD subtype in LC patients...
4.
Kim H, Lee J, Oh I, Kim E, Yoon S, Lee S, et al.
Cancers (Basel)
. 2024 Feb;
16(3).
PMID: 38339278
Real-world data on the use and outcomes of crizotinib in ROS1-rearranged non-small-cell lung cancer (NSCLC) are limited. This study aims to analyze the real-world efficacy of crizotinib in South Korea...
5.
Kim Y, Kim Y, Jeong D, Kim S, Kim M, Kim H, et al.
Semin Arthritis Rheum
. 2024 Jan;
65:152362.
PMID: 38281468
Background: To investigate the risk of recurrent herpes zoster (HZ) reactivation under continued Janus kinase inhibitor (JAKi) therapy in patients with immune-mediated inflammatory diseases (IMID) who developed HZ reactivation. Methods:...
6.
Kim H, Kim H, Shim T, Ahn J, Huh J, Hong S, et al.
Respir Res
. 2023 Dec;
24(1):307.
PMID: 38062465
Background: Acute exacerbation of interstitial lung disease (AE-ILD) significantly impacts prognosis, leading to high mortality rates. Although lung transplantation is a life-saving treatment for selected patients with ILD, its outcomes...
7.
Kim H, Kim S, Kim M, Jung C, Chong Y, Shim T, et al.
Antimicrob Agents Chemother
. 2023 May;
67(6):e0167522.
PMID: 37222618
In a 1:4 case-control matched analysis of data from a nationwide population-based cohort in South Korea, we evaluated whether metformin use mitigates the risk of nontuberculous mycobacterial disease in patients...
8.
Kim H, Jo K, Shim T, Ji W, Ahn J, Oh D, et al.
Sci Rep
. 2023 Jan;
13(1):667.
PMID: 36635329
Airway complications may occur after lung transplantation and are associated with considerable morbidity and mortality. We investigated the incidence, risk factors, and clinical characteristics of these complications. We retrospectively reviewed...